|
HY-119283-25mg
|
MedChemexpress LLC
|
MAGL-IN-5 [CAS 359714-55-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-119283-5mg
|
MedChemexpress LLC
|
MAGL-IN-5 [CAS 359714-55-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-119283-50mg
|
MedChemexpress LLC
|
MAGL-IN-5 [CAS 359714-55-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-P1280-1mg
|
MedChemexpress LLC
|
Margatoxin [CAS 145808-47-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1280-100ug
|
MedChemexpress LLC
|
Margatoxin [CAS 145808-47-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1280-500ug
|
MedChemexpress LLC
|
Margatoxin [CAS 145808-47-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-W014004-10mg
|
MedChemexpress LLC
|
m-Carboxycinnamic acid bishydroxamide [CAS 174664-65-4]
|
|
Cancer-programmed cell death
|
|
|
HY-W014004-5mg
|
MedChemexpress LLC
|
m-Carboxycinnamic acid bishydroxamide [CAS 174664-65-4]
|
|
Cancer-programmed cell death
|
|
|
HY-B0574-10g
|
MedChemexpress LLC
|
Mefenamic acid [CAS 61-68-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0574-5g
|
MedChemexpress LLC
|
Mefenamic acid [CAS 61-68-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0574-500mg
|
MedChemexpress LLC
|
Mefenamic acid [CAS 61-68-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0574-1mL
|
MedChemexpress LLC
|
Mefenamic acid [CAS 61-68-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-B0574S-1mg
|
MedChemexpress LLC
|
Mefenamic acid-d4 [CAS 1216745-79-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0574S-5mg
|
MedChemexpress LLC
|
Mefenamic acid-d4 [CAS 1216745-79-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-D0950A-100mg
|
MedChemexpress LLC
|
Methyl Green (zinc chloride) [CAS 7114-03-6]
|
|
|
|
|
HY-D0950A-500mg
|
MedChemexpress LLC
|
Methyl Green (zinc chloride) [CAS 7114-03-6]
|
|
|
|
|
HY-D0163-1g
|
MedChemexpress LLC
|
Methyl Green [CAS 14855-76-6]
|
|
|
|
|
HY-D0163-100mg
|
MedChemexpress LLC
|
Methyl Green [CAS 14855-76-6]
|
|
|
|
|
HY-D0163-500mg
|
MedChemexpress LLC
|
Methyl Green [CAS 14855-76-6]
|
|
|
|
|
HY-D0163-1mL
|
MedChemexpress LLC
|
Methyl Green [CAS 14855-76-6] (10mM in DMSO)
|
|
|
|
|
HY-10680-1mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10680-10mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10680-100mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10680-5mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10680-50mg
|
MedChemexpress LLC
|
MK-6892 [CAS 917910-45-3]
|
|
Cancer-programmed cell death
|
|
